Residual Fatigue and Cognitive Deficits in Patients After Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 33779685.
- Also identified by DOI 10.1001/jamaneurol.2021.0477 and PMC identifier 8008400.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This study evaluates residual fatigue and cognitive defects in patients after leucine-rich glioma-inactivated 1 antibody encephalitis.
Medical subject headings
- Cognitive Dysfunction
- Encephalitis
- Fatigue
- Glioma
- Leucine